Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMY-25271 is an antagonist of histamine H2 receptor.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | BMY-25271 is an antagonist of histamine H2 receptor. |
In vivo | The dose-response curves are parallel and oral ED50 values derived from probit analysis are 0.093, 0.97, and 6.9 mg/kg for BMY-25271, ranitidine, and cimetidine, respectively. BMY-25271 is about 10 and 74 times more potent than ranitidine and cimetidine, respectively. |
分子量 | 329.44 |
分子式 | C12H19N5O2S2 |
CAS No. | 78441-82-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMY-25271 78441-82-4 GPCR/G Protein Immunology/Inflammation Neuroscience Histamine Receptor BMY 25271 BMY25271 Inhibitor inhibitor inhibit